Delta4 is an AI Drug Discovery Biotech Company that focuses on discovering undetected relationships between drugs with a known safety profile and diseases to identify new indications. Delta4 utilizes Hyper-C (standing for Hyper Connectivity), a platform housing an enormous collection of algorithmic intelligence. It is operated by a team of highly skilled computational biologists that carefully analyze the data to produce unique insights and opportunities.
The platform feeds on big data and uses its algorithms and data integration to build molecular models which go through an iterative refinement process matching them to diseases. This sophisticated process utilizing thousands of pre-computed models effectively matches compounds to diseases for more efficient biological testing and clinical trials. Delta4 is looking for service projects with pharma companies and for strategic partners in the development of their own pipeline assets.